Хірургічна реваскуляризація міокарда при стабільній ішемічній хворобі серця. Quo vadis?

Главни садржај чланка

O. A. Yepanchintseva
O. J. Zharinov
B. M. Todurov

Анотація

У статті проаналізовано сучасні дані про роль операції аортокоронарного шунтування (АКШ) у пацієнтів зі стабільною ішемічною хворобою серця. Наведено принципи передопераційної оцінки ризику та вибору між АКШ і перкутанним коронарним втручанням. На підставі результатів контрольованих досліджень визначено показання для операції АКШ в узгоджених рекомендаціях. Оцінка життє­­здатності міокарда та коронарного резерву дає можливість покращити відбір пацієнтів для реваскуляризаційних втручань. З позицій доказової медицини розглянуто предиктори ранніх післяопераційних ускладнень та результати тривалого спостереження за пацієнтами, які перенесли АКШ. Можливими проміжними критеріями ефективності реваскуляризації є зміни насосної функції лівого шлуночка та показники якості життя. Окрему увагу приділено перспективам використання нових хірургічних технологій для покращення результатів АКШ.

Ключові слова

Стабільна ішемічна хвороба серця, аортокоронарне шунтування, показання, ускладнення, ефективність

Завантаження

Дані завантаження ще не доступні.

Детаљи чланка

Посилання

Посилання

Borkhalenko YuA, Zharinov OY, Mikhaliev KO, Yepanchintseva OA, Todurov BM. Zminy yakosti zhyttia ta kryterii efektyvnosti aortokoronarnoho shuntuvannia u patsiientiv zi stabilnoiu IKhS i zberezhenoiu fraktsiieiu vykydu livoho shlunochka. Kardiokhirurhiia ta interventsiina kardiolohiia [Cardiac Surgery and Interventional Cardiology]. 2018;2:14–23. (in Ukr.). http://csic.com.ua/ua/nomery/arkhiv-nomeriv/2-2018/851-sekventsiine-koronarne-shuntuvannia-iak-prohres-koronarnoi-khirurhii-19

Ivaniuk NB, Zharinov OY, Mikhaliev KO, Yepanchintseva OA, Todurov BM. Zminy fraktsii vykydu livoho shlunochka v patsiientiv z ishemichnoiu kardiomiopatiieiu pislia aortokoronarnoho shuntuvannia. Ukrainskyi kardiolohichnyi zhurnal [Ukrainian Journal of Cardiology]. 2016;4:45–54. (in Ukr.). http://journal.ukrcardio.org/wp-content/uploads/2016/04/4_4_2016.pdf

Problemy zdorov’ia i tryvalosti zhyttia v suchasnykh umovakh. Pid red. VM Kovalenka, VM Kornatskoho. K., 2017.300p. (in Ukr.).

Abdallah MS, Wang K, Magnuson EA, Spertus JA, Farkouh ME, Fuster V, Cohen DJ; FREEDOM Trial Investigators. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. JAMA 2013;310:1581–1590. http://doi.org/10.1001/jama.2013.279208

Adjedj J, De Bruyne B, Floré V, Di Gioia G, Ferrara A, Pellicano M, Toth GG, Bartunek J, Vanderheyden M, Heyndrickx GR, Wijns W, Barbato E. Significance of intermediate values of fractional flow reserve in patients with coronary artery disease. Circulation. 2016;133:502–508. doi: http://doi.org/10.1161/CIRCULATIONAHA.115.018747.

Ahn JM, Roh JH, Kim YH, Park DW, Yun SC, Lee PH, Chang M, Park HW, Lee SW, Lee CW, Park SW, Choo SJ, Chung C, Lee J, Lim DS, Rha SW, Lee SG, Gwon HC, Kim HS, Chae IH, Jang Y, Jeong MH, Tahk SJ, Seung KB, Park SJ. Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT Study. J Am Coll Cardiol. 2015;65:2198–2206. doi: http://doi.org/10.1016/j.jacc.2015.03.033.

Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB Jr, Lorenz TJ, Goyal A, Gibson M, Mack MJ, Gennevois D, Califf RM, Kouchoukos NT; PREVENT IV Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294:2446–2454. https://jamanetwork.com/journals/jama/fullarticle/201881

Alexander JH, Smith PK. Coronary artery bypass grafting. NewEngl J Med 2017; 374:1954–1964. Doi: http://doi.org/10.1056/NEJMra1406944.

Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. JACC. 2002;39(7):1151–1158. https://www.ncbi.nlm.nih.gov/pubmed/11923039

Anavekar NS, Chareonthaitawee P, Narula J, Gersh BJ. Revascularization in Patients With Severe Left Ventricular Dysfunction: Is the Assessment of Viability Still Viable? J Am Coll Cardiol. 2016;67(24):2874–87. doi: http://doi.org/10.1016/j.jacc.2016.03.571.

Baber U, Farkouh ME, Arbel Y, Muntner P, Dangas G, Mack MJ, Hamza TH, Mehran R, Fuster V. Comparative Efficacy of Coronary Artery Bypass Surgery vs. Percutaneous Coronary Intervention in Patients With Diabetes and Multivessel Coronary Artery Disease With or Without Chronic Kidney Disease. Eur Heart J. 2016;37(46):3440–3447. http://doi.org/10.1093/eurheartj/ehw378

Bakaeen FG, Shroyer AL, Gammie JS, Sabik JF, Cornwell LD, Coselli JS, Rosengart TK, O'Brien SM, Wallace A, Shahian DM, Grover FL, Puskas JD. Trends in use of off-pump coronary artery bypass grafting: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. J Thorac Cardiovasc Surg. 2014;148:856–863, 864.e1. doi: http://doi.org/10.1016/j.jtcvs.2013.12.047.

Baron SJ, Chinnakondepalli K, Magnuson EA, Kandzari DE, Puskas JD, Ben-Yehuda O, van Es GA, Taggart DP, Morice MC, Lembo NJ, Brown WM, Banning A, Simonton CA, Kappetein AP, Sabik JF, Serruys PW, Stone GW, Cohen DJ; EXCEL Investigators. Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial. J Am Coll Cardiol. 2017;70(25):3113–3122. doi: http://doi.org/10.1016/j.jacc.2017.10.036.

Bingham SE, Hachamovitch R. Incremental prognostic significance of combined cardiac magnetic resonance imaging, adenosine stress perfusion, delayed enhancement, and left ventricular function over preimaging information for the prediction of adverse events. Circulation 2011;123:1509–1518. http://doi.org/10.1161/CIRCULATIONAHA.109.907659

Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T, Michler RE, Berman DS, Nicolau JC, Pellikka PA, Wrobel K, Alotti N, Asch FM, Favaloro LE, She L, Velazquez EJ, Jones RH, Panza JA; STICH Trial Investigators. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617–1625. https://www.nejm.org/doi/full/10.1056/NEJMoa1100358

Brener SJ, Lytle BW, Casserly IP, Schneider JP, Topol EJ, Lauer MS. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation. 2004;109:2290–2295. http://doi.org/10.1161/01.CIR.0000126826.58526.14

Castleberry AW, Williams JB, Daneshmand MA, Honeycutt E, Shaw LK, Samad Z, Lopes RD, Alexander JH, Mathew JP, Velazquez EJ, Milano CA, Smith PK. Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience. Circulation 2014; 129: 2547–56. http://doi.org/10.1161/CIRCULATIONAHA.113.005223

De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, Jagic N, Mobius-Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd K, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Limacher A, Nüesch E, Jüni P; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med. 2014;371:1208–1217. doi: http://doi.org/10.1056/NEJMoa1408758.

Deppe AC, Arbash W, Kuhn EW, Slottosch I, Scherner M, Liakopoulos OJ, Choi YH, Wahlers T. Current evidence of coronary artery bypass grafting off-pump versus on-pump: a systematic review with meta-analysis of over 16,900 patients investigated in randomized controlled trials. Eur J Cardiothorac Surg. 2016;49:1031–1041. doi: http://doi.org/10.1093/ejcts/ezv268.

Doherty J, Kort S, Mehran R, Schoenhagen P, Soman P. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Nucl Cardiol. 2017;24(5):1759–1792. http://doi.org/10.1007/s12350-017-0917-9

ElBardissi AW, Aranki SF, Sheng S, O'Brien SM, Greenberg CC, Gammie JS. Trends in isolated coronary artery bypass grafting: an analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. J Thorac Cardiovasc Surg. 2012;143:273–281. doi: http://doi.org/10.1016/j.jtcvs.2011.10.029.

Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367:2375–2384. doi: http://doi.org/10.1056/NEJMoa1211585.

Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, Kappetein AP, Colombo A, Holmes DR Jr, Mack M, Feldman T, Morice MC, Ståhle E, Onuma Y, Morel MA, Garcia-Garcia HM, van Es GA, Dawkins KD, Mohr FW, Serruys PW. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013;381:639–650. http://doi.org/10.1016/S0140-6736(13)60108-7

Gąsior M, Zembala MO, Tajstra M, Filipiak K, Gierlotka M, Hrapkowicz T, Hawranek M, Poloński L, Zembala M; POL-MIDES (HYBRID) Study Investigators. Hybrid revascularization for multivessel coronary artery disease. JACC Cardiovasc Interv. 2014;7:1277–1283. doi: http://doi.org/10.1016/j.jcin.2014.05.025.

Gimelli A, Neto JA, Marcassa C, Ferrazzi P, Glauber M, Marzullo P. Beneficial effects of coronary revascularization in patients with ischemic left ventricular dysfunction with and without angina symptoms. Interactive Cardiovascular and Thoracic Surgery.2002;1: 9–15. https://academic.oup.com/icvts/article/1/1/9/683494

Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2014 update: a report from the American Heart Association . Circulation. 2014;129:28–292. http://doi.org/10.1161/01.cir.0000441139.02102.80

Haxhibeqiri-Karabdic I, Hasanovic A, Kabil E, Straus S. Improvement of ejection fraction after coronary artery bypass grafting surgery in patients with impaired left ventricular function. Med Arh.2014;68(5):332–334. http://doi.org/10.5455/medarh.2014.68.332-334

Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR Jr, Feldman TE, Ståhle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J. 2014;35:2821–2830. doi: http://doi.org/10.1093/eurheartj/ehu213.

Head SJ, Kaul S, Mack MJ, Serruys PW, Taggart DP, Holmes DR Jr, Leon MB, Marco J, Bogers AJ, Kappetein AP. The rationale for heart team decision making for patients with stable, complex coronary artery disease. Eur Heart J. 2013;34:2510–2518. doi: http://doi.org/10.1093/eurheartj/eht059.

Head SJ, Kieser TM, Falk V, Huysmans HA, Kappetein AP. Coronary artery bypass grafting: part 1: the evolution over the first 50 years. Eur Heart J. 2013;34:2862–2872. doi: http://doi.org/10.1093/eurheartj/eht330.

Head Stuart J., Milojevic Milan, Taggart David P., Puskas John D. Current practice of state-of-the-art surgical coronary revascularization. Circulation. 2017;136(14):1331–1345. http://doi.org/10.1161/CIRCULATIONAHA.116.022572

Head SJ, Parasca CA, Mack MJ, Mohr FW, Morice MC, Holmes DR Jr, Feldman TE, Dawkins KD, Colombo A, Serruys PW, Kappetein AP; SYNTAX Investigators. Differences in baseline characteristics, practice patterns and clinical outcomes in contemporary coronary artery bypass grafting in the United States and Europe: insights from the SYNTAX randomized trial and registry. Eur J Cardiothorac Surg. 2015;47:685–695. doi: http://doi.org/10.1093/ejcts/ezu197.

Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, Cigarroa JE, Disesa VJ, Hiratzka LF, Hutter AM Jr, Jessen ME, Keeley EC, Lahey SJ, Lange RA, London MJ, Mack MJ, Patel MR, Puskas JD, Sabik JF, Selnes O, Shahian DM, Trost JC, Winniford MD. ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. Journal of the American College of Cardiology 2011;58(24):1–90. https://www.ahajournals.org/doi/10.1161/CIR.0b013e31823c074e

Hlatky MA, Boothroyd DB. Comparative effectiveness of multivessel coronary artery bypass graft surgery and multivessel percutaneous coronary intervention. Ann Intern Med 2013;159:435. http://doi.org/10.7326/0003-4819-158-10-201305210-00639

Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, Carrié D, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kähler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009;373:1190–1197. doi: http://doi.org/10.1016/S0140-6736(09)60552-3.

Holmes DR Jr, Taggart DP. Revascularization in stable coronary artery disease: A combined perspective from an interventional cardiologist and a cardiac surgeon. Eur Heart J. 2016;37(24):1872–1873. doi: http://doi.org/10.1093/eurheartj/ehw044

Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D, Rocha AS, Hueb AC, Ramires JA. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010;122:949–957. doi: http://doi.org/10.1161/CIRCULATIONAHA.109.911669.

Iqbal J, Zhang YJ, Holmes DR, Morice MC, Mack MJ, Kappetein AP, Feldman T, Stahle E, Escaned J, Banning AP, Gunn JP, Colombo A, Steyerberg EW, Mohr FW, Serruys PW. Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up. Circulation. 2015;131:1269–1277. doi: http://doi.org/10.1161/CIRCULATIONAHA.114.013042.

Jones DS. CABG at 50 (or 107?) – the complex course of therapeutic innovation. New Engl J Med 2017;376:1809–1811. http://doi.org/10.1056/NEJMp1702718

Kalogeropoulos AP, Fonarow GC, Georgiopoulou V. Characteristics and outcomes of adult outpatients with heart failure and improved or recovered ejection fraction. JAMA Cardiol. Published online July 06, 2016. doi: http://doi.org/10.1001/jamacardio.2016.1356.

Kang D-Y, Ahn J-M, Lee CH, Lee PH, Park D-W, Kang S-J, Lee S-W, Kim Y-H, Lee CW, Park S-W, Park S-J. Deferred vs. performed revascularization for coronary stenosis with grey-zone fractional flow reserve values: data from the IRISFFR registry. Eur Heart J 2018;39:1610–1619. http://doi.org/10.1093/eurheartj/ehy079

Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, Straka Z, Piegas LS, Akar AR, Jain AR, Noiseux N, Padmanabhan C, Bahamondes JC, Novick RJ, Vaijyanath P, Reddy S, Tao L, Olavegogeascoechea PA, Airan B, Sulling TA, Whitlock RP, Ou Y, Ng J, Chrolavicius S, Yusuf S; CORONARY Investigators. Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med. 2012;366:1489–1497. doi: http://doi.org/10.1056/NEJMoa1200388.

Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Straka Z, Piegas LS, Avezum A, Akar AR, Lanas Zanetti F, Jain AR, Noiseux N, Padmanabhan C, Bahamondes JC, Novick RJ, Tao L, Olavegogeascoechea PA, Airan B, Sulling TA, Whitlock RP, Ou Y, Gao P, Pettit S, Yusuf S; CORONARY Investigators. Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting. N Engl J Med. 2016;375(24):2359–2368. http://doi.org/10.1056/NEJMoa1601564

Mäkikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, Trovik T, Eskola M, Romppanen H, Kellerth T, Ravkilde J, Jensen LO, Kalinauskas G, Linder RB, Pentikainen M, Hervold A, Banning A, Zaman A, Cotton J, Eriksen E, Margus S, Sørensen HT, Nielsen PH, Niemelä M, Kervinen K, Lassen JF, Maeng M, Oldroyd K, Berg G, Walsh SJ, Hanratty CG, Kumsars I, Stradins P, Steigen TK, Fröbert O, Graham AN, Endresen PC, Corbascio M, Kajander O, Trivedi U, Hartikainen J, Anttila V, Hildick-Smith D, Thuesen L, Christiansen EH; NOBLE Study Investigators. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet. 2016;388:2743–2752. doi: http://doi.org/10.1016/S0140-6736(16)32052-9.

Mark DB, Knight JD, Velazquez EJ, Wasilewski J, Howlett JG, Smith PK, Spertus JA, Rajda M, Yadav R, Hamman BL, Malinowski M, Naik A, Rankin G, Harding TM, Drew LA, Desvigne-Nickens P, Anstrom KJ. Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: а randomized trial. Ann Intern Med 2014;161(6):392–399. http://doi.org/10.7326/M13-1380

Mehaffey JH, Hawkins RB, Byler M, Charles EJ, Fonner C, Kron I, Quader M, Speir A, Rich J, Ailawadi G; Virginia Cardiac Services Quality Initiative. Cost of individual complications following coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2018 Mar;155(3):875–882.e1. doi: http://doi.org/10.1016/j.jtcvs.2017.08.144.

Meharwal ZS, Trehan N. Off-pump coronary artery bypass grafting in patients with left ventricular dysfunction. Heart Surgery Forum 2002;5(1):41–45. https://www.ncbi.nlm.nih.gov/pubmed/11937461

Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ, Acker MA, Hung JW, Chang HL, Perrault LP, Gillinov AM, Argenziano M, Bagiella E, Overbey JR, Moquete EG, Gupta LN, Miller MA, Taddei-Peters WC, Jeffries N, Weisel RD, Rose EA, Gammie JS, DeRose JJ Jr, Puskas JD, Dagenais F, Burks SG, El-Hamamsy I, Milano CA, Atluri P, Voisine P, O'Gara PT, Gelijns AC; CTSN. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 2016;374:1932–41. https://www.nejm.org/doi/full/10.1056/NEJMoa1602003

Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR Jr, Morel MA, Van Dyck N, Houle VM, Dawkins KD, Serruys PW. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381:629–638. doi: http://doi.org/10.1016/S0140-6736(13)60141–5.

Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ; ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL. 2013 ESC guidelines on the management of stable coronary artery disease.The task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur. Heart J. 2013;34:2949–3003. http://doi.org/10.1093/eurheartj/eht296

Morice MC, Serruys PW, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR, Choi JW, Ruzyllo W, Religa G, Huang J, Roy K, Dawkins KD, Mohr F. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery Trial. Circulation. 2014;129:2388– 2394. doi: http://doi.org/10.1161/CIRCULATIONAHA.113.006689.

Murphy A, Johnson CO, Roth GA, Forouzanfar MH, Naghavi M, Ng M, Pogosova N, Vos T, Murray CJL, Moran AE. Ischaemic heart disease in the former Soviet Union 1990–2015 according to the Global Burden of Disease 2015 Study. Heart 2018;104:58–66. doi: http://doi.org/10.1136/heartjnl-2016-311142

Nagendran J, Bozso SJ, Norris CM, McAlister FA, Appoo JJ, Moon MC, Freed DH, Nagendran J. Coronary Artery Bypass Surgery Improves Outcomes in Patients With Diabetes and Left Ventricular Dysfunction. J Am Coll Cardiol 2018;71:819–827. http://doi.org/10.1016/j.jacc.2017.12.024

Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–744. doi: http://doi.org/10.1093/ejcts/ezs043.

Niebauer J. Is there a role for cardiac rehabilitation after coronary artery bypass grafting? Treatment after coronary artery bypass surgery remains incomplete without rehabilitation. Circulation. 2016;133:2529–2537. doi: http://doi.org/10.1161/CIRCULATIONAHA.116.021348.

Organisation for Economic Cooperation and Development. Health at a Glance 2015. Paris: OECD Publishing; 2015. http://apps.who.int/medicinedocs/documents/s22177en/s22177en.pdf

Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Choo SJ, Chung CH, Lee JW, Cohen DJ, Yeung AC, Hur SH, Seung KB, Ahn TH, Kwon HM, Lim DS, Rha SW, Jeong MH, Lee BK, Tresukosol D, Fu GS, Ong TK; BEST Trial Investigators. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med. 2015;372:1204–1212. doi: http://doi.org/10.1056/NEJMoa1415447.

Petrie MC, Jhund PS, She L, Adlbrecht C, Doenst T, Panza JA, Hill JA, Lee KL, Rouleau JL, Prior DL, Ali IS, Maddury J, Golba KS, White HD, Carson P, Chrzanowski L, Romanov A, Miller AB, Velazquez EJ; STICH Trial Investigators. Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure). Circulation 2016 Nov 1;134(18):1314–1324. doi: http://doi.org/10.1161/CIRCULATIONAHA.116.024800.

Piątek J, Kędziora A, Kiełbasa G, Olszewska M, Sobczyk D, Song BH, Konstanty-Kalandyk J, Darocha T, Wierzbicki K, Milaniak I, Wróbel K, Kapelak B. How to predict the risk of postoperative complications after coronary artery bypass grafting in patients under 50 and over 80 years old? A retrospective cross-sectional study. Polish Heart Journal 2017;75(10):975–982. doi: http://doi.org/10.5603/KP.a2017.0120

Pinho-Gomes AC, Azevedo L, Ahn JM, Park SJ, Hamza TH, Farkouh ME, Serruys PW, Milojevic M, Kappetein AP, Stone GW, Lamy A, Fuster V, Taggart DP. Compliance with guideline-directed medical therapy in contemporary coronary revascularization trials. J Am Coll Cardiol 2018;71:591–602. http://doi.org/10.1016/j.jacc.2017.11.068

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members; Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 2016;37:2129–2200. https://academic.oup.com/eurheartj/article/37/27/2129/1748921

Rouleau JL, Bonow RO. An approach to the rational use of revascularization in heart failure patients. Canad J Cardiol 2014;30:281–287. http://doi.org/10.1016/j.cjca.2013.11.012

Selnes OA, Gottesman RF, Grega MA, Baumgartner WA, Zeger SL, McKhann GM. Cognitive and neurologic outcomes after coronary-artery bypass surgery. N Engl J Med. 2012;366:250–257. doi: http://doi.org/10.1056/NEJMra1100109.

Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models, part 1: coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88:S2–S22. http://doi.org/10.1016/j.athoracsur.2009.05.053

Smith PK1, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, Hung JW, Parides MK, Ailawadi G, Perrault LP, Acker MA, Argenziano M, Thourani V, Gammie JS, Miller MA, Pagé P, Overbey JR, Bagiella E, Dagenais F, Blackstone EH, Kron IL, Goldstein DJ, Rose EA, Moquete EG, Jeffries N, Gardner TJ, O'Gara PT, Alexander JH, Michler RE; Cardiothoracic Surgical Trials Network Investigators. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 2014;371:2178–88. http://doi.org/10.1056/NEJMoa1410490

Stone GW, Sabik JF, Serruys PW, Simonton CA, Généreux P, Puskas J, Kandzari DE, Morice MC, Lembo N, Brown WM, Taggart DP, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman P, Bochenek A, Schampaert E, Pagé P, Dressler O, Kosmidou I, Mehran R, Pocock SJ, Kappetein AP; EXCEL Trial Investigators. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med. 2016 Dec 8;375(23):2223–2235. https://www.nejm.org/doi/full/10.1056/NEJMoa1610227

Tabata M, Grab JD, Khalpey Z, Edwards FH, O'Brien SM, Cohn LH, Bolman RM 3rd. Prevalence and variability of internal mammary artery graft use in contemporary multivessel coronary artery bypass graft surgery: analysis of the Society of Thoracic Surgeons National Cardiac Database. Circulation. 2009;120:935–940. doi: http://doi.org/10.1161/CIRCULATIONAHA.108.832444.

Taggart DP, Altman DG, Gray AM, Lees B, Nugara F, Yu LM, Campbell H, Flather M; ART Investigators. Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). Eur Heart J. 2010;31:2470– 2481. doi: http://doi.org/10.1093/eurheartj/ehq318.

Taggart DP, Altman DG, Gray AM, Lees B, Gerry S, Benedetto U, Flather M; ART Investigators. Randomized trial of bilateral versus single internalthoracic-artery grafts. N Engl J Med. 2016;375:2540–2549. doi: http://doi.org/10.1056/NEJMoa1610021.

Taggart DP, Thomas B. Ferguson lecture. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know. Ann Thorac Surg 2006;82:1966–1975. http://doi.org/10.1016/j.athoracsur.2006.06.035

The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS). 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart. J. 2018. Doi: http://doi.org/10.1093/eurheartj/ehy394

Toth G, De Bruyne B, Casselman F, De Vroey F, Pyxaras S, Di Serafino L, Van Praet F, Van Mieghem C, Stockman B, Wijns W, Degrieck I, Barbato E. Fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. Circulation. 2013;128:1405–1411. doi: http://doi.org/10.1161/CIRCULATIONAHA.113.002740.

Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018 Jan 14;39(3):213–260. doi: http://doi.org/10.1093/eurheartj/ehx419.

Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL; STICH Investigators. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011;364:1607–1616. http://doi.org/10.1056/NEJMoa1100356

Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL; STICHES Investigators. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374:1511–1520. doi: http://doi.org/10.1056/NEJMoa1602001.

Waldo SW, Secemsky EA, O'Brien C, Kennedy KF, Pomerantsev E, Sundt TM 3rd, McNulty EJ, Scirica BM, Yeh RW. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention. Circulation 2014;130:2295–2301. http://doi.org/10.1161/CIRCULATIONAHA.114.011541

Wang TK, Li AY, Ramanathan T, Stewart RA, Gamble G, White HD. Comparison of four risk scores for contemporary isolated coronary artery bypass grafting. Heart Lung Circ. 2014;23:469–474. doi: http://doi.org/10.1016/j.hlc.2013.12.001.

Weintraub WS, Grau-Sepulveda MV, Weiss JM, O'Brien SM, Peterson ED, Kolm P, Zhang Z, Klein LW, Shaw RE, McKay C, Ritzenthaler LL, Popma JJ, Messenger JC, Shahian DM, Grover FL, Mayer JE, Shewan CM, Garratt KN, Moussa ID, Dangas GD, Edwards FH. Comparative effectiveness of revascularization strategies. N Engl J Med 2012;366:1467–1476. http://doi.org/10.1056/NEJMoa1110717

Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 2014;46(4):517–592. http://doi.org/10.1093/eurheartj/ehu278

Windecker S, Stortecky S, Stefanini GG, da Costa BR, Rutjes AW, Di Nisio M, Silletta MG, Maione A, Alfonso F, Clemmensen PM, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter D, Schauerte P, Sousa Uva M, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A, Kolh P, Jüni P. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ 2014;348:g3859. http://doi.org/10.1136/bmj.g3859.

Wrobel K, Stevens SR, Jones RH, Selzman CH, Lamy A, Beaver TM, Djokovic LT, Wang N, Velazquez EJ, Sopko G, Kron IL, DiMaio JM, Michler RE, Lee KL, Yii M, Leng CY, Zembala M, Rouleau JL, Daly RC, Al-Khalidi HR. Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. Circulation. 2015;132(8):720–30. doi: http://doi.org/10.1161/CIRCULATIONAHA.114.014932.

Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R, Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344(8922):563–570. https://www.ncbi.nlm.nih.gov/pubmed/7914958

Zhang Z, Mahoney EM, Stables RH, Booth J, Nugara F, Spertus JA, Weintraub WS. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery. One-year results from the Stent or Surgery Trial. Circulation 2003;108(14):1694–1700. http://doi.org/10.1161/01.CIR.0000087600.83707.FD

##plugins.generic.recommendByAuthor.heading##

1 2 > >>